DocSym
β
Searchsearch
Search
(D05.0) Lobular carcinoma in situ
More details coming soon
420 275 in individuals diagnosis lobular carcinoma in situ confirmed
4 007 deaths with diagnosis lobular carcinoma in situ
1% mortality rate associated with the disease lobular carcinoma in situ
Diagnosis lobular carcinoma in situ is diagnosed Women are 99.28% more likely than Men
1 522
Men receive the diagnosis lobular carcinoma in situ
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
418 753
Women receive the diagnosis lobular carcinoma in situ
4 007 (1.0 %)Died from this diagnosis.
Risk Group for the Disease lobular carcinoma in situ - Men aged 70-74 and Women aged 50-54
In Men diagnosis is most often set at age 40-49, 70-74, 85-89
Less common in men the disease occurs at Age 0-39, 50-69, 75-84, 90-95+Less common in women the disease occurs at Age 0-14, 95+
In Women diagnosis is most often set at age 0-1, 15-94
Disease Features lobular carcinoma in situ
Absence or low individual and public risk
Lobular carcinoma in situ - what does this mean
More details coming soon
What happens during the disease - lobular carcinoma in situ
Lobular carcinoma in situ (lcis) is a type of breast cancer in which abnormal cells are found in the lobules of the breast. it is thought to be caused by a combination of genetic and environmental factors, such as age, family history, and exposure to certain hormones. it is believed that these factors cause genetic mutations in the cells of the lobules, leading to uncontrolled cell growth and the formation of lcis.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Biopsy
- Mammogram
- Ultrasound
- Magnetic resonance imaging (MRI)
- Computed tomography (CT) scan
- Positron emission tomography (PET) scan
- Blood tests
- Genetic testing
Treatment and Medical Assistance
Main goal of the treatment: To reduce the risk of Lobular Carcinoma In Situ progressing to invasive cancer.
- Regular mammograms and breast exams to monitor for signs of progression
- Chemoprevention with medications to reduce risk of progression
- Surveillance with biopsies to detect any changes
- Surgery to remove the affected area
- Radiation therapy to reduce the risk of recurrence
- Hormone therapy to reduce the risk of recurrence
12 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Lobular carcinoma in situ - Prevention
Lobular carcinoma in situ (lcis) can be prevented through regular self-examinations of the breasts, regular visits to the doctor for mammograms and clinical breast exams, and maintaining a healthy lifestyle with a balanced diet and regular exercise.